Strong Sales Momentum Maintained as Operating Leverage Boosts the Bottom Line; Raising Resmed's FVE
Strong sales momentum from first-quarter fiscal 2018 continued, with narrow-moat ResMed reporting another excellent quarter, ahead of our...
171 Views
Human Longevity
At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...
526 Views
Aussie Healthcare Daily: 12 & 13 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
416 Views
Time to Look at the Laggards in Aussie Healthcare
Australian Growth stocks have under-performed in the past four years, but they generally perform well in a rising global interest rate...
414 Views
Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?
While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...
3.2k Views